top of page
INSIGHTS
Search
Two-Days International Symposium on Strategies for Managing Pharmaceutical, Biotechnology & Chemical Patent Portfolios
We are happy to inform you all that IIPRD and Khurana & Khurana, in association with Cantor Colburn (US) and Fukami Patent Office (Japan)...
Dec 13, 20131 min read
Inventors, All Technologies Aren’t Worth Billions
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate commercial viability of numerous IP...
Jul 31, 20118 min read
Anti Cancer drug: Making it Patient-driven, not Disease-driven
Introduction: French compatriots Ipsen and bioMérieux, have been few most potential companies, since 2007 in the development of...
Apr 11, 20114 min read
bottom of page